Navigation Links
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
Date:2/11/2009

methylergonovine, cisapride, pimozide, oral midazolam, triazolam, lovastatin, or simvastatin).
  • Coadministration of PREZISTA/r is also contraindicated with rifampin and products containing St. John's wort (Hypericum perforatum) because this may cause significant decrease in plasma concentration of darunavir, resulting in loss of therapeutic effect and development of resistance.
  • Coadministration is not recommended with indinavir, lopinavir/ritonavir, saquinavir, and pravastatin.
  • Caution should be used when prescribing agents such as sildenafil, vardenafil, tadalafil, or other substrates, inhibitors, or inducers of CYP3A in patients receiving PREZISTA/r. This list of potential drug interactions is not complete.
  • Additional Important Safety Information

    • Do not use PREZISTA/r in pediatric patients below 3 years of age. The safety and efficacy of PREZISTA/r in pediatric patients 3 to < 6 years of age have not been established.
    • PREZISTA must be coadministered with ritonavir and food to achieve the desired antiviral effect. Failure to administer PREZISTA with ritonavir and food may result in a loss of efficacy of darunavir. Please refer to ritonavir prescribing information for additional information on precautionary measures.
    • Drug-induced hepatitis (eg, acute hepatitis, cytolytic hepatitis) has been reported with PREZISTA/r. Patients with preexisting liver dysfunction, including chronic active hepatitis B or C, have an increased risk for liver function abnormalities, including severe hepatic adverse events.

    Post-marketing cases of liver injury, including some fatalities, have been reported. A causal relationship with PREZISTA/r therapy has not been established.

    Appropriate laboratory testing should be conducted prior to initiating therapy with PREZISTA/r and patients shoul
    '/>"/>

    SOURCE Tibotec Therapeutics
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine news :

    1. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
    2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
    3. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
    4. Tickets Still Available for Detroit Uncorked;
    5. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
    6. Experts, Advocates Available to Comment on Hillary Clintons Health Care Plan
    7. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
    8. New Resource for Taking Care of Aging Parents Available in Beta
    9. 2007/2008 Pharmaceutical R&D Factbook Published by CMR International is Now Available
    10. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
    11. Updated Brochure on Gynecologic Cancer Treatments Now Available
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... ... , ... Mesa Community College graduate, Andrew Sypher (Mesa), is one ... rigor, leadership and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, ... medallion and a $7,500 scholarship to assist in his goal of becoming a foreign ...
    (Date:8/27/2015)... ... August 27, 2015 , ... ... cost to treat a patient with hemophilia is $175,000. Hemophilia is an inherited, ... and improving treatment. The RMHBDA exists to help raise funds for patients suffering ...
    (Date:8/27/2015)... ... 2015 , ... According to an article published August 13 by ... many conversations between hernia experts surrounding the search for the ideal hernia mesh. With ... experts have different ideas about which is the best mesh for their patients. What ...
    (Date:8/27/2015)... Denver, CO (PRWEB) , ... August 27, 2015 , ... ... author examined the current policing situation in the city of New Orleans, highlighting a ... Force, the firm is run by a tech oriented entrepreneur who worked with the ...
    (Date:8/27/2015)... , ... August 27, 2015 , ... ... , is one of just 20 adult-only medical centers in the United States ... with failing hearts and lungs. The Extracorporeal Life Support Organization (ELSO) , ...
    Breaking Medicine News(10 mins):Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4
    ... family history data supports heredity,s role in shoulder tendon tearsROSEMONT, ... rotator cuff tears are at increased ... published in the May 2009 issue of The ... (JBJS). "This strongly suggests genetic predisposition as a possible cause ...
    ... crisis improved long-term outcomes, study found , , FRIDAY, May ... drug during a coronary emergency can save lives and ... , The one-year risk of death or major heart ... episodes of acute coronary syndrome who received the drugs, ...
    ... Mexico -- thought to be source of outbreak -- reports ... -- The number of confirmed swine flu cases in the ... but the infections continue to be mild. , In response ... for all Americans against the never-before-seen flu strain, but the ...
    ... Presented at American Heart Association ATVB Conference Shows Reduction ... in Treated PatientsWASHINGTON and SAN FRANCISCO, May 1 ... announced the results of a sub-study of patients in ... received serial 64 slice multidetector computed tomography (MDCT) scans ...
    ... a leading online consumer advocacy group, has announced the ... skin care and anti-aging websites, http://www.NewImageSpecialists.com ... cosmetic market, New Image Specialists, growing popularity has led ... network of more than 300 medical spas and laser ...
    ... 1 SCOLR Pharma, Inc. (NYSE Amex: DDD ... 31, 2009. The Company will host a live conference ... Time).Bruce S. Morra, SCOLR Pharma,s President and CEO, stated, "Our ... lead product candidates, ibuprofen and pseudoephedrine, and the support of ...
    Cached Medicine News:Health News:Rotator Cuff Tears: Are They All in the Family? 2Health News:Rotator Cuff Tears: Are They All in the Family? 3Health News:Cholesterol Drugs May Help in Cardiac Emergency 2Health News:Swine Flu Infections Near 110 in U.S. 2Health News:Swine Flu Infections Near 110 in U.S. 3Health News:Swine Flu Infections Near 110 in U.S. 4Health News:Swine Flu Infections Near 110 in U.S. 5Health News:Swine Flu Infections Near 110 in U.S. 6Health News:Swine Flu Infections Near 110 in U.S. 7Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 2Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 3Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 4Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 5Health News:SignatureForum Introduces NewImageSpecialists.com 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 3Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 4Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 5Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 6Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 7
    (Date:8/27/2015)... -- Biosimilars are not generics and the Biologics ... Drug Administration (FDA) for recognizing that each biosimilar ... issued today. The FDA,s draft guidance on nonproprietary ... for biological products to bear a nonproprietary name ... the agency,s thinking that "there is a need ...
    (Date:8/27/2015)... 2015  Now that Intuitive Surgical, Inc.® has announced ... robot, hospitals with robotic surgery programs need to think ... see where they stand with robotic surgery. Are they ... they adopted best practices for safety? Should they plan ... ECRI Institute, which has nearly 50 years, ...
    (Date:8/27/2015)... , Aug. 27, 2015  A mere one ... Booz Allen Hamilton . A new white ... development inefficiencies are impeding and disrupting manufacturers, success. ... Waste and Improve Value In Product Development Processes ... inaccessible data and how it affects the product development ...
    Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2
    ... Incorporated (NASDAQ: GPRO ) announced today that the Company ... 28, 2011 at approximately 4:00 pm Eastern Time (ET). The announcement ... pm ET.   The conference call will be webcast ... Company,s web site at www.gen-probe.com . An archived version of ...
    ... July 14, 2011 Span-America Medical Systems, Inc. (NASDAQ: ... rebroadcast of its conference call on Friday, July 29, 2011, ... be released after the regular close of trading the preceding ... will be available online at www.spanamerica.com under investor ...
    Cached Medicine Technology:Gen-Probe Announces Webcast of Second Quarter 2011 Earnings Conference Call 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: